Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of California, San Francisco

About this trial

Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode following a night of disrupted or poor-quality sleep. This prospective, randomized, case-crossover study aims to examine the acute effects of sleep disruption on clinically relevant cardiac ectopy pertinent to AF.

Eligibility criteria

Qualifiers

Are age 21 years or older

Have a HGNS device implanted for obstructive sleep apnea and followed up at UCSF Health

Are willing to abstain from using the upper airway stimulation device for no more than two consecutive days as instructed over the 14-day trial period

Able and willing to provide written informed consent

Disqualifiers

Currently pregnant or trying to get pregnant

Are currently taking class 1 or 3 anti-arrhythmic medications

Have a history of permanent AF or expected to have continuous AF throughout the study period

Have congenital heart disease

Trial design

Treatments tested in this trial

  • HGNS Use Randomized Instructions

Treatment groups

100 Participants
are divided into 2 treatment groups